Importantly, treatment regimens were highly tolerated, with no critical adverse situations documented. Ketamine-induced dissociative and psychotomimetic signs were being transient, resolving totally within 1–2?h on common. However, findings with regards to efficacy remain mixed, with the biggest RCT87 failing to determine major dose-connected eff